期刊文献+

429例系统性硬化症患者伴发肌病的临床分析 被引量:3

Prevalence and clinical significance of systemic sclerosis-associated myopathy in 429 patients
原文传递
导出
摘要 目的 探讨系统性硬化症(systemic sclerosis,SSc)伴发肌病患者的临床特征.方法 对2009年2月~2015年12月在北京协和医院欧洲抗风湿病联盟硬皮病试验研究组(European scleroderma trials and researchgroup,EUSTAR)数据库中收集的SSc患者的肌肉合并症进行横断面分析,比较SSc伴发肌病组和无肌病组的流行病学及临床资料,分析两组间的差异.结果 共有资料完整患者429人纳入本研究,平均发病年龄为(39.3±12.6)岁,SSc伴发肌病的发生率为22.6%.两组比较,肌病组的早饱/呕吐(x2=16.29,P<0.001)、吞咽困难(x2=27.01,P<0.001)、浮肿(x2=17.74,P<0.001)及尿量减少(Х^2=4.59,P=0.032)发生率高于无肌病组.SSc伴发肌病组超声心动图检查提示肺动脉压升高的发生率(Х^2 =6.31,P=0.012)高于无肌病组.SSc伴发肌病组的血沉(t =1.06,P=0.011)和C反应蛋白水平(t=0.87,P=0.001)高于无肌病组.结论 SSc伴发肌病不少见,与疾病的炎症程度及肾脏受累、心脏和肺并发症相关,临床需加强对SSc伴发肌病患者的关注并警惕与心脏和肾脏相关的并发症. Objective To explore the prevalence of and clinical manifestation associated with myopathy in Chinese patients with systemic sclerosis(SSc).Methods This study was a cross-sectional study based on European Scleroderma Trials and Research group (EUSTAR) database in Peking Union Medical College Hospital(PUMCH) from February 2009 to December 2015.Demographic,clinical and laboratory data were analyzed in groups with and without myopathy.Results Of 429 Chinese SSc patients whose mean age of onset was (39.3 ± 12.6) years old.Overall prevalence of myopathy was 22.6%.The presence of early satiety/vomiting(x2 =16.29,P 〈 0.001),dysphagia (x2 =27.01,P 〈 0.001),edema (x2 =17.74,P 〈0.001),and urine decreased(x2 =4.59,P =0.032) occurred more frequent in patients with myopathy than those without myopathy.The abnormal rate of pulmonary arterial hypertension (PAH) detected by echocardiography in the myopathy group was higher than that of non-myopathy group (x2 =6.31,P =0.012).The elevation of erythrocyte sedimentation rate (t =1.06,P =0.011) and C reactive protein (t =0.87,P =0.001) were more higher in myopathy group than in non-myopathy group.Conclusions SSc associated myopathy is not uncommon.Compared to non-myopathy patients,SSc patients associated myopathy have a more severe inflammation response,and require more attention on cardiac and renal complications.
出处 《中华疾病控制杂志》 CAS CSCD 北大核心 2016年第10期995-998,1003,共5页 Chinese Journal of Disease Control & Prevention
基金 国家自然科学基金(81102268)
关键词 硬皮病 系统性 肌疾病 肌炎 Sclerosis, systemic Myopathy Myositis
  • 相关文献

参考文献2

二级参考文献31

  • 1Low AHL, Johnson SR, Lee P. Ethnic Influence on diseasemanifestations and autoantibodies in Chinese-descent patients with systemic sclerosis. J Rheumatol, 2009, 36: 787-793. 被引量:1
  • 2Chifflot H, Fautzi B, Sorder C, et al. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum, 2008, 37: 223-235. 被引量:1
  • 3Armando G, Enrico VA, Thomas K.Scleroderma. N Engl J bled, 2009, 360: 1989-2003. 被引量:1
  • 4Walker UA, Tyndall A, Czirj6k L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research Group database. Ann Rheum Dis, 2007, 66: 754-763. 被引量:1
  • 5Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research Group (EUSTAR) database of systemic sclerosis patients. Ann Rheum Dis, 2010, 69: 218- 221. 被引量:1
  • 6Hegedus I, Czirjak L. Left ventrieular wall motion abnormalities in 80 patients with systemic sclerosis. Clin Rheumatol, 1995, 14: 161-164. 被引量:1
  • 7Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum, 2000, 43: 2437-2444. 被引量:1
  • 8Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology, 2006, 45 : 14-17. 被引量:1
  • 9Ariane H. Diagnosis and management of scleroderma peripheral vascular disease. Rheum Dis Clin Nor Am, 2008, 34: 89-114. 被引量:1
  • 10Newman AB, Siscovick DS, Manolio TA, et al. Ankle-armindex as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CI-IS) Collaborative Research Group. Circulation, 1993, 88: 837-845. 被引量:1

共引文献22

同被引文献13

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部